SEER data: It can be thought provoking, but where do we go from here?

Annals of Surgical Oncology

Volumn 14, Issue 8, 2007, Pages 2173-2174

  Petrelli, Nicholas J ^a  

^a HELEN F GRAHAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURVIVAL; CYTOREDUCTIVE SURGERY; DEMOGRAPHY; EDITORIAL; EPIDEMIOLOGICAL DATA; HEALTH PROGRAM; HUMAN; PROBABILITY; SCORING SYSTEM;

BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FORECASTING; HUMANS; NEOPLASM METASTASIS; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL RATE; THINKING; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 34547477071     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9453-1     Document Type: Editorial

References (5)

1. Khan SA, Stewart AK, Morrow M. Does aggressive local therapy improve survival in metastatic breast cancer? Surgery 2002; 132:620-627
2. Babiera GV, Rao R, Feng L, et al. Effect of primary tumor extirpation in breast cancer patients who present with stage IV disease and an intact primary tumor. Ann Surg Oncol 2006; 13(6):776-782
3. Rapiti E, Verkooijen HM, Vlastos G, et al. Complete excision of primary breast tumor improves survival of patients with metastatic breast cancer at diagnosis. J Clin Oncol 2006; 24:2743-2749
4. Retsky M, BonadonnaG, Demicheli R, Folkman J, Hrushesky W, Valagussa P. Hypothesis: induced angiogenesis after surgery in premenopausal node-positive breast cancer patients is a major underlying reason why adjuvant chemotherapy works particularly well for those patients. Breast Cancer Res 2004; 6:R372-R374
5. Danna EA, Sinha P, Gilbert M, et al. Surgical removal of the primary tumor reverses tumor-induced immunosuppression despite the presence of metastatic disease. Cancer Res 2004; 64:2205-2211